文献速递外周动脉疾病

血管内碎石术治疗膝下钙化病变:Disrupt PAD III 观察性研究结果

Intravascular Lithotripsy for Treatment of Calcified Infrapopliteal Lesions: Results from the Disrupt PAD III Observational Study.
PubMed 文献 · J Endovasc Ther · 2021-08-12

该研究为前瞻性、非随机、多中心单臂观察性研究,纳入101例患者共114条膝下钙化动脉,使用Shockwave S4血管内碎石导管治疗。69.3%患者为临界肢体缺血,平均参考血管直径3.1±0.8 mm,平均病变长度64.7±54.7 mm,中重度钙化占69.3%。术后平均急性获得2.0±0.7 mm,99.0%病变残余狭窄<50%,无血流限制性夹层、栓塞、慢血流/无复流或急性闭塞事件。

要点

  • S4 IVL导管在膝下钙化病变中实现99.0%残余狭窄<50%,平均急性获得2.0±0.7 mm。
  • 69.3%患者为CLI,中重度钙化占69.3%,病变复杂但急性安全事件为零。
  • 22.7%手术使用辅助钙修饰技术(刻痕/切割球囊和/或斑块旋切)。

核心结论

  • Shockwave S4血管内碎石导管在真实世界膝下钙化病变患者中表现出与既往IVL外周研究一致的急性安全性和有效性。

研究设计与样本

  • Disrupt PAD III观察性研究(NCT02923193)为前瞻性、非随机、多中心单臂研究,评估Shockwave外周IVL系统的真实世界急性安全性和有效性。
  • 本亚分析纳入2018年7月至2020年8月来自3个国家15个中心的101例患者共114条膝下钙化动脉,均使用Shockwave S4 IVL导管治疗。
  • 入组标准为跛行或临界肢体缺血且造影评估至少中度钙化。

主要发现

  • 69.3%患者存在临界肢体缺血,胫前动脉和胫腓干是最常治疗的血管。
  • 核心实验室评估平均参考血管直径3.1±0.8 mm,最小管腔直径0.5±0.6 mm,直径狭窄83.4%±15.8%。
  • 平均病变长度64.7±54.7 mm,按PARC标准中重度钙化占69.3%。
  • 术后平均急性获得2.0±0.7 mm,99.0%病变残余狭窄<50%,平均残余狭窄23.3±12.5%。
  • 手术结束时无血流限制性夹层、栓塞、慢血流/无复流或急性闭塞事件。

关键数值与推荐

  • 22.7%的手术使用了辅助钙修饰技术,定义为刻痕或切割球囊和/或斑块旋切。

临床怎么用

  • 对于膝下钙化病变,可考虑使用Shockwave S4 IVL导管进行预处理以获得良好的急性管腔获得。
  • IVL可单独或联合辅助钙修饰技术使用,本研究中22.7%手术联合了刻痕/切割球囊或斑块旋切。

局限性

  • 本研究为单臂观察性研究,非随机对照,无法直接比较IVL与其他治疗方式的优劣。
  • 样本量有限(101例患者114条动脉),随访仅限急性期,缺乏长期耐久性数据。
  • 入组患者为真实世界连续病例,但仅纳入造影评估至少中度钙化者,存在选择偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the safety and effectiveness of the Shockwave S4 intravascular lithotripsy (IVL) catheter in an "all-comers" cohort of patients with calcified infrapopliteal lesions. MATERIALS AND METHODS: The Disrupt PAD III Observational Study (NCT02923193) is a prospective, nonrandomized, multicenter single-arm study designed to assess the "real-world" acute safety and effectiveness of the Shockwave Peripheral IVL System for the treatment of de novo calcified, stenotic peripheral arteries. Patients were eligible for enrollment if they had claudication or critical limb ischemia (CLI) and at least moderate calcification as assessed by angiography. This subanalysis includes consecutive patients enrolled with angiographic core lab-assessed treatment of infrapopliteal arteries using the Shockwave S4 IVL catheter. RESULTS: From July 2018 to August 2020, 101 patients with 114 calcified infrapopliteal arteries treated with the S4 IVL catheter were enrolled at 15 sites in 3 countries. CLI was present in 69.3% of patients. The anterior tibial and tiboperoneal trunk were the most commonly treated vessels with an overall mean reference vessel diameter (RVD) of 3.1±0.8 mm, minimum lumen diameter (MLD) of 0.5±0.6 mm, and a corresponding diameter stenosis of 83.4%±15.8% by core lab assessment. Mean lesion length was 64.7±54.7 mm with moderate to severe calcification in 69.3% of lesions by the Peripheral Academic Research Consortium (PARC) criteria. Adjunctive calcium-modifying technology, defined as scoring or cutting balloon and/or atherectomy, was used in 22.7% of procedures. The average acute gain at the end of the procedure was 2.0±0.7 mm with a residual stenosis <50% achieved in 99.0% of lesions and a mean residual stenosis of 23.3±12.5%. There were no flow-limiting dissection, embolization, slow flow/no-reflow, or abrupt closure events at the end of the procedure. CONCLUSION: This subanalysis of the PAD III Observational Study represents the largest report to-date of IVL treatment of heavily calcified below-the-knee (BTK) lesions in a "real-world" patient cohort. The use of S4 IVL demonstrated consistent acute safety and effectiveness outcomes consistent with prior IVL peripheral studies. These consistent outcomes were achieved with the initial use of the S4 IVL catheter for treatment of complex BTK lesions.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Adams G, Soukas PA, Mehrle A, et al. Intravascular Lithotripsy for Treatment of Calcified Infrapopliteal Lesions: Results from the Disrupt PAD III Observational Study. J Endovasc Ther. 2021. PMID: 34380334. doi:10.1177/15266028211032953

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。